← Back to Search

Vascular Closure Device

MANTA Vascular Closure Device for Femoral Artery Closure (MANTA ULTRA Trial)

N/A
Waitlist Available
Led By David Wood
Research Sponsored by Essential Medical, Inc.
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Be older than 18 years old
Timeline
Screening 3 weeks
Treatment Varies
Follow Up during procedure admission
Awards & highlights

MANTA ULTRA Trial Summary

This trial demonstrates the safety of the MANTA Vascular Closure Device, which uses ultrasound to guide closure of the femoral artery, in patients undergoing elective TAVR procedures.

MANTA ULTRA Trial Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~within 30 days
This trial's timeline: 3 weeks for screening, Varies for treatment, and within 30 days for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Rate of Any Large Bore Access-site Related VARC-2 Major Vascular Complication
Secondary outcome measures
Number of Patients With Technical Success
Number of Subjects With Ambulation Success
Procedure Time
+4 more

MANTA ULTRA Trial Design

1Treatment groups
Experimental Treatment
Group I: Ultrasound ClosureExperimental Treatment1 Intervention
Open label, single arm study using ultrasound guidance during MANTA device deployment.
Treatment
First Studied
Drug Approval Stage
How many patients have taken this drug
MANTA Vascular Closure Device
2015
N/A
~50

Find a Location

Who is running the clinical trial?

TeleflexIndustry Sponsor
20 Previous Clinical Trials
4,667 Total Patients Enrolled
Essential Medical, Inc.Lead Sponsor
5 Previous Clinical Trials
1,110 Total Patients Enrolled
David WoodPrincipal InvestigatorVancouver General Hospital

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

What is today's patient recruitment goal for this research project?

"The sponsor, Teleflex, needs to enroll 180 eligible patients from various clinical trial sites - including Washington Hospital Center in Washington, District of Columbia and Sentara Northern Virginia Medical Center in Woodbridge, Virginia - in order to complete the study."

Answered by AI

If I'm interested in participating in this trial, how many different places can I go to?

"This study is being conducted in several hospitals, including Washington Hospital Center, Sentara Northern Virginia Medical Center, and University of Buffalo."

Answered by AI

Are there any presently open vacancies for patients in this experiment?

"The trial is still recruiting patients, as indicated by the 8/24/2022 edit date on clinicaltrials.gov. The listing for this study was first posted on 8/9/2022."

Answered by AI
~7 spots leftby Mar 2025